US: 800.298.5699
Int'l: +1.240.747.3093
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
|
Home > Back to Publisher > Report Information
Neurocrine Biosciences, Incorporated
SGA Lists
October 1, 2009
2 Pages - Pub ID: SGA2462872
|
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, certain female and male disorders, anxiety, depression, diabetes, irritable bowel syndrome, eating disorders, pain, and autoimmunity.
Related Reports:
Investing in Stem Cell Companies in 2010 and Beyond
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
Company Financials: Life Technologies Corporation
Company Financials: Maxygen, Inc.
Company Financials: Amgen, Inc.
Company Financials: AspenBio Pharma
Company Financials: Sangamo Biosciences, Inc.
Company Financials: Genomic Health
|
|
(0 items)
Email a colleague
Printer format
Questions about this report
Order by fax
